(Q35019817)

5 August 2017

1 reference

title

Chronic renal ischemia: implications for cardiovascular disease risk (English)

1 reference

5 August 2017

main subject

cardiovascular disease

1 reference

1 reference

Timothy P Murphy

1

1 reference

5 August 2017

John H Rundback

series ordinal

2

1 reference

5 August 2017

Christopher Cooper

series ordinal

3

1 reference

5 August 2017

M Susan Kiernan

series ordinal

4

1 reference

5 August 2017

publication date

1 December 2002

1 reference

Journal of Vascular and Interventional Radiology

5 August 2017

published in

1 reference

5 August 2017

volume

13

1 reference

5 August 2017

issue

12

1 reference

5 August 2017

page(s)

1187-1198

1 reference

Comparison of target organ damage in renovascular and essential hypertension

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

A hemodynamic comparison of essential and renovascular hypertension. Cardiac output and total peripheral resistance: supine and tilted patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Prevalence of Renovascular Hypertension in Patients with Grade III or IV Hypertensive Retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Renovascular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Randomised trial of treatment of hypertension in elderly patients in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

The Effects of Blood Pressure Reduction in Older Patients: An Overview of Five Randomized Controlled Trials in Elderly Hypertensives

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Prevalence of primary and secondary hypertension: studies in a random population sample.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Cost and yield of the hypertensive evaluation. Experience of a community-based referral clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Renal artery stenosis and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Chronic renal ischemia: pathophysiologic mechanisms of cardiovascular and renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Renin, Aldosterone, Body Fluid Volumes, and the Baroreceptor Reflex in the Development and Reversal of Goldblatt Hypertension in Conscious Dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Intrarenal renin-angiotensin-sodium interdependent mechanism controlling postclamp renal artery pressure and renin release in the conscious dog with chronic one-kidney Goldblatt hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

The adrenal renin-angiotensin system: a local hormonal regulator of aldosterone production.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Contribution of stenosis resistance to the rise in total peripheral resistance during experimental renal hypertension in conscious dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

The sixth Volhard Lecture: Causal and homoeostatic factors in hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Renal and systemic effects of enalapril in chronic one-kidney hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

The role of angiotensin II in the development of hypertension and in the maintenance of glomerular filtration rate during 48 hours of renal artery stenosis in conscious dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Cardiac structure and function in renovascular hypertension produced by unilateral and bilateral renal artery stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Endothelin and active renin levels in essential hypertension and hypertension with renal artery stenosis before and after percutaneous transluminal renal angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Renal vein renin analysis: limitations of its use in predicting benefit from percutaneous angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Neurogenic components of hypertension in human renal artery stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Endothelial function and oxidative stress in renovascular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Relation of plasma renin to end organ damage and to protection of K+ feeding in stroke-prone hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

RENAL ARTERY STENOSIS. A CLINICAL-PATHOLOGIC STUDY IN NORMOTENSIVE AND HYPERTENSIVE PATIENTS.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Excess prevalence of extracranial carotid artery lesions in renovascular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Screening for carotid and renal artery stenoses in patients with aortoiliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

The coronary risk of unsuspected renal artery stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

The natural history of incidental renal artery stenosis in patients with aortoiliac vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

"Apparent" heart failure: a syndrome caused by renal artery stenoses

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Progression of renal artery stenosis in patients undergoing cardiac catheterization.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

The prevalence and associated risk factors of renal artery stenosis in patients undergoing cardiac catheterization

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

High incidence of renal artery stenosis in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Prevalence and predictors of renal artery stenosis in patients with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Determination of renal arterial stenosis severity: comparison of pressure gradient and vessel diameter

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Renal artery pressure gradients in patients with angiographic evidence of atherosclerotic renal artery stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Hypertension with renal arterial stenosis: Humoral, hemodynamic and histopathologic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Increased sympathetic nerve activity in renovascular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Clinical predictors of improved long-term blood pressure control after successful stenting of hypertensive patients with obstructive renal artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Relation of left ventricular hypertrophy, afterload, and contractility to left ventricular performance in Goldblatt hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Left ventricular structural characteristics in unilateral renovascular hypertension and primary aldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Renal artery stenosis in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Effects of renal artery stent implantation in patients with renovascular hypertension presenting with unstable angina or congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Preoperative haemodynamic evaluation of patients submitted for renal artery stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Acute renal failure, tubular necrosis, and myocardial infarction induced in the rabbit by intravenous angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Endothelin System–Dependent Cardiac Remodeling in Renovascular Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Left ventricular insulin-like growth factor I increases in early renal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Differential effects of angiotensin II versus endothelin-1 inhibitions in hypertrophic left ventricular myocardium during transition to heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Angiotensin II: rapid localization in nuclei of smooth and cardiac muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Interaction between endothelin and angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Left ventricular hypertrophy and mortality--results from the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Left ventricular hypertrophy as a surrogate end-point in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Left ventricular hypertrophy: effect on survival

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Effects of the correction of renal artery stenosis on blood pressure, renal function and left ventricular morphology

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Ischemic renal disease: an overlooked clinical entity?

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Atherosclerotic renal artery stenosis: is it worth diagnosing?

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Prospective study of atherosclerotic disease progression in the renal artery

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerte

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Outcomes of atherosclerotic renal artery stenosis managed without revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Clinical course of atherosclerotic renovascular disease∗

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Effects of ramipril on coronary events in high-risk persons: results of the Heart Outcomes Prevention Evaluation Study

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Hypertension and renal artery stenosis: Serial observations on 54 patients treated medically

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Survival associated with renovascular disease in Glasgow and Newcastle: a collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Labelling of hypertensives: a review of the data

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

A comparison of antihypertensive medication utilization before and after guideline changes using the Department of Defense Prescription Database

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Functional and biochemical analysis of angiotensin II-forming pathways in the human heart

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Endogenous angiotensin II levels and the mechanism of action of angiotensin-converting enzyme inhibitors and angiotensin receptor type 1 antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Stent placement for renal arterial stenosis: where do we stand? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Renal artery stent placement: long-term results with the Wallstent endoprosthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Stent placement in ostial and nonostial atherosclerotic renal arterial stenoses: a prospective follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

Atherosclerotic renal artery stenosis: ostial or truncal?

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961964-2

7 January 2021

10.1016/S1051-0443(07)61964-2

Identifiers

DOI

1 reference

5 August 2017

1 reference